Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.


Summaries of Product Characteristics 61 - 90 of 285
Previous 30    |  1  2  3  4  5  6  7  8  9  10  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti

Lenalidomid Zentiva 2,5 mg, 5 mg, 7,5 mg (PER), 10 mg, 15 mg, 20 mg, 25 mg kovat kapselit SPC 2023-12-22

European Medicines Agency's website:
Lenalidomide Accord - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Lenalidomide Grindeks 2,5 mg, 5 mg, 7,5 mg, 10 mg, 15 mg, 20 mg, 25 mg kapseli, kova SPC 2022-06-13.docx

European Medicines Agency's website:
Lenalidomide Krka (ent. Lenalidomide Krka d.d. Novo mesto) - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Lenalidomide Mylan - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Lenalidomide Orion 5 mg, 10 mg, 15 mg, 20 mg, 25 mg kapseli, kova SPC 2023-10-31

PL

Resepti

Lenalidomide ratiopharm 2.5 mg (PER), 5 mg, 7.5 mg (PER), 10 mg, 15 mg, 20 mg, 25 mg kapseli kova SPC 2024-03-21

PL

Resepti

Lenalidomide Sandoz 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 25 mg kapseli, kova valmisteyhteenveto 2024-04-04

PL

Resepti

Lenalidomide Stada 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg ja 25 mg kapseli, kova SPC 2024-03-18

European Medicines Agency's website:
Lenvima - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Lenzetto 1,53 mg-suihke transdermaalisumute, liuos SPC 2024-01-10

PL

Resepti

Leponex 25 mg, 100 mg, 200 mg tabletti SPC 2024-11-04 Uusi

PL

Resepti

Leponex 25 mg, 100 mg, 200 mg tabletti SPC 2024-11-04 Uusi

European Medicines Agency's website:
Leqvio - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Lercamed 10 mg ja 20 mg tabletti, kalvopäällysteinen SPC 2024-03-28.docx

PL

Resepti

Lercanidipin Hydrochlorid Actavis 10 mg, 20 mg tabletti, kalvopäällysteinen SPC 2023-09-25

PL

Resepti

Lercanidipine Hydrochloride Accord 10 mg, 20 mg tabletti, kalvopäällysteinen SPC 2022-09-08

PL

Resepti

Lesamor 80 mg-12.5 mg tabletti SPC 2021-11-24

PL

Resepti

Lescol Depot 80 mg depottabletti SPC 2024-01-23

PL

Resepti

Letrolan 2.5 mg tabletti, kalvopäällysteinen SPC 2021-02-23

PL

Resepti

Letrozol Accord 2,5 mg tabletti, kalvopäällysteinen SPC 2023-08-04

PL

Resepti

Letrozol ratiopharm 2,5 mg tabletti, kalvopäällysteinen SPC 2020-05-19.doc

PL

Resepti

Letrozol Ratiopharm 2.5 tabletti SPC 2019-08-28

PL

Resepti

Letrozol STADA 2.5 mg tabletti, kalvopäällysteinen SPC 2021-04-21

PL

Resepti

Letrozole Sandoz 2.5 mg tabletti, kalvopäällysteinen SPC 2024-08-01

PL

Resepti

Letybo 50 IU injektiokuiva-aine, liuosta varten SPC 2023-07-05

PL

Resepti

Leukeran 2 mg tabletti, kalvopäällysteinen SPC 2021-11-18

PL

Resepti

Leuprorelin Sandoz 5 mg implantaatti, esitäytetty ruisku SPC 2024-06-14

European Medicines Agency's website:
Levemir - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Levesia100 mikrog- 20 mikrog kalvopäällysteinen tabletti SPC 2023-07-17

Previous 30    |  1  2  3  4  5  6  7  8  9  10  |  Next 30   >